US4732752A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Polyvalent equine immune serum composition and method for treating rheumatoid arthritis
Assignee: PETER STEPHAN CENTER Ltd A FLORIDA PARTNERSHIP
•
Filing: 1986-10-23
•
Granted: 1988-03-22
•
Expires: 2006-10-23
Abstract
Abstract A composition and method for treating rheumatoid arthritis, osteoarthritis, and related diseases which comprises administering an effective amount of an equine immune serum, in dosage form, to a patient. The equine immune serum is obtained from horses which have been immunized with a solution containing tissue from prenatal or pregnant pigs.
Inventors
- 👤 Peter M. Stephan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 22:57
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S424/00; Y10S424/81; Y10S530/00; Y10S530/868
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
37 words
A therapeutic composition in dosage form comprising a pharmaceutically acceptable carrier and a polyvalent equine immune serum which contains antibodies to pig bone marrow, bone tissue, thymus, spleen, lymphatic ganglia, parathyroid gland, connective tissue, and serous membranes.
Claim 2
Dependent Claim
37 words
A therapeutic composition in dosage form comprising a pharmaceutically acceptable carrier and a polyvalent equine immune serum which contains antibodies to pig bone marrow, bone tissue, thymus, spleen, lymphatic ganglia, parathyroid gland, connective tissue, and serous membranes.
Claim 3
Dependent Claim
18 words
A composition according to claim 1 wherein said pharmaceutically acceptable carrier is in the form of a suppository.
Claim 4
Dependent Claim
18 words
A composition according to claim 1 wherein said pharmaceutically acceptable carrier is in a form suitable for injection.
Claim 5
Dependent Claim
25 words
A composition according to claim 1 wherein said equine immune serum is present in an amount of between about 0.15 and 1.25 mls per dose.
Claim 6
Independent Claim
61 words
A method of treating rheumatoid arthritis, osteoarthritis, and other related diseases which comprises administering to a patient having rheumatoid arthritis, osteoarthritis or a related disease, an effective amount of a composition having as the essential active ingredient a polyvalent equine immune serum containing antibodies to pig bone marrow, bone tissue, thymus, spleen, lymphatic ganglia, parathyroid gland, connective tissue, and serous membranes.
Claim 7
Independent Claim
61 words
A method of treating rheumatoid arthritis, osteoarthritis, and other related diseases which comprises administering to a patient having rheumatoid arthritis, osteoarthritis or a related disease, an effective amount of a composition having as the essential active ingredient a polyvalent equine immune serum containing antibodies to pig bone marrow, bone tissue, thymus, spleen, lymphatic ganglia, parathyroid gland, connective tissue, and serous membranes.
Claim 8
Dependent Claim
14 words
A method according to claim 5 wherein said composition is administered in suppository form.
Claim 9
Dependent Claim
13 words
A method according to claim 5 wherein said composition is administered by injection.
Claim 10
Dependent Claim
17 words
A method according to claim 5 wherein said effective amount is 0.15 to 1.25 mls per dose.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-03-22 | 1991-09-21 | 1992-03-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-03-22 | 1995-09-21 | 1996-03-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-03-22 | 1999-09-21 | 2000-03-22 | $7700.00 | Window Closed / Lapsed |